Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms

다국어 초록 (Multilingual Abstract)

Systemic cancer and ischemic stroke are common conditions and two of the most frequent causes of death among the elderly. The association between cancer and stroke has been reported worldwide. Stroke causes severe disability for cancer patients, while cancer increases the risk of stroke. Moreover, cancer-related stroke is expected to increase due to advances in cancer treatment and an aging population worldwide. Because cancer and stroke share risk factors (such as smoking and obesity) and treatment of cancer can increase the risk of stroke (e.g., accelerated atherosclerosis after radiation therapy), cancer may accelerate conventional stroke mechanisms (i.e., atherosclerosis, small vessel disease, and cardiac thrombus). In addition, active cancer and chemotherapy may enhance thrombin generation causing stroke related to coagulopathy. Patients with stroke due to cancer-related coagulopathy showed the characteristics findings of etiologic work ups, D-dimer levels, and infarct patterns. In this review, we summarized the frequency of cancer-related stroke among patients with ischemic stroke, mechanisms of stroke with in cancer patients, and evaluation and treatment of cancer-related stroke. We discussed the possibility of cancer-related stroke as a stroke subtype, and presented the most recent discoveries in the pathomechanisms and treatment of stroke due to cancerrelated coagulopathy.

참고문헌 (Reference)

1 Mandalà M, "Venous thromboembolism(VTE)in cancer patients : ESMO clinical recommendations for prevention and management" 125 (125): S117-S119, 2010

2 Lyman GH, "Venous thromboembolism prophylaxis and treatment in patients with cancer : American Society of Clinical Oncology clinical practice guideline update 2014" 33 : 654-656, 2015

3 Lyman GH, "Venous thromboembolism prophylaxis and treatment in patients with cancer : American Society of Clinical Oncology clinical practice guideline update" 31 : 2189-2204, 2013

4 Ferroni P, "Validation of a machine learning approach for venous thromboembolism risk prediction in oncology" 2017 : 8781379-, 2017

5 Leal AC, "Tumor-derived exosomes induce the formation of neutrophil extracellular traps : implications for the establishment of cancer-associated thrombosis" 7 : 6438-, 2017

6 Sanossian N, "Trends in cancer diagnoses among inpatients hospitalized with stroke" 22 : 1146-1150, 2013

7 Posch F, "Treatment of venous thromboembolism in patients with cancer : a network meta-analysis comparing efficacy and safety of anticoagulants" 136 : 582-589, 2015

8 Nam KW, "Treatment of cryptogenic stroke with active cancer with a new oral anticoagulant" 26 : 2976-2980, 2017

9 Jang HS, "The long-term effect of cancer on incident stroke : a nationwide population-based cohort study in Korea" 10 : 52-, 2019

10 Marnane M, "Stroke subtype classification to mechanismspecific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study" 41 : 1579-1586, 2010

11 Schwarzbach CJ, "Stroke and cancer : the importance of cancer-associated hypercoagulation as a possible stroke etiology" 43 : 3029-3034, 2012

12 Conen D, "Risk of malignant cancer among women with newonset atrial fibrillation" 1 : 389-396, 2016

13 Zöller B, "Risk of haemorrhagic and ischaemic stroke in patients with cancer : a nationwide follow-up study from Sweden" 48 : 1875-1883, 2012

14 Erichsen R, "Risk of colorectal cancer in patients with acute myocardial infarction and stroke : a nationwide cohort study" 22 : 1994-1999, 2013

15 Navi BB, "Risk of arterial thromboembolism in patients with cancer" 70 : 926-938, 2017

16 Gomes M, "Risk assessment for thrombosis in cancer" 40 : 319-324, 2014

17 Prandoni P, "Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis" 100 : 3484-3488, 2002

18 Parikh NS, "Recurrent thromboembolic events after ischemic stroke in patients with primary brain tumors" 26 : 2396-2403, 2017

19 Lysov Z, "Procoagulant effects of lung cancer chemotherapy : impact on microparticles and cell-free DNA" 28 : 72-82, 2017

20 Jung S, "Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke" 24 : 520-528, 2018

21 Selvik HA, "Prior cancer in patients with ischemic stroke : the Bergen NORSTROKE study" 23 : 919-925, 2014

22 Shin YW, "Predictors of survival for patients with cancer after cryptogenic stroke" 128 : 277-284, 2016

23 Cocho D, "Predictors of occult cancer in acute ischemic stroke patients" 24 : 1324-1328, 2015

24 Duffy S, "Per-pass analysis of thrombus composition in patients with acute ischemic stroke undergoing mechanical thrombectomy" 50 : 1156-1163, 2019

25 Kimura H, "Pathologic study of intracranial large artery atherosclerosis in 7260 autopsy cases" 26 : 2821-2827, 2017

26 Sousou T, "New insights into cancer-associated thrombosis" 29 : 316-320, 2009

27 Amarenco P, "New approach to stroke subtyping : the A-SC-O(phenotypic)classification of stroke" 27 : 502-508, 2009

28 Brinkmann V, "Neutrophil extracellular traps kill bacteria" 303 : 1532-1535, 2004

29 Thålin C, "NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation" 139 : 56-64, 2016

30 Streiff MB, "NCCN guidelines insights: cancer-associated venous thromboembolic disease, version 2.2018" 16 : 1289-1303, 2018

31 Navi BB, "Multifocal stroke from tumor emboli" 66 : 1174-1175, 2009

32 Chen PC, "Lung cancer and incidence of stroke : a population-based cohort study" 42 : 3034-3039, 2011

33 Reitter EM, "Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment" 14 : 294-305, 2016

34 Kim SG, "Ischemic stroke in cancer patients with and without conventional mechanisms : a multicenter study in Korea" 41 : 798-801, 2010

35 Gon Y, "Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism" 154 : 16-18, 2017

36 Navi BB, "Ischemic stroke in cancer patients : a review of an underappreciated pathology" 83 : 873-883, 2018

37 Plummer C, "Ischemic stroke and transient ischemic attack after head and neck radiotherapy : a review" 42 : 2410-2418, 2011

38 Iguchi Y, "Ischaemic stroke with malignancy may often be caused by paradoxical embolism" 77 : 1336-1339, 2006

39 Farge D, "International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer" 17 : e452-e466, 2016

40 Zuo PY, "Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab : a meta-analysis" 9 : e102484-, 2014

41 Daniel Addison, "Incidental Statin Use and the Risk of Stroke or Transient Ischemic Attack after Radiotherapy for Head and Neck Cancer" 대한뇌졸중학회 20 (20): 71-79, 2018

42 Khorana AA, "Incidence and predictors of venous thromboembolism(VTE)among ambulatory high-risk cancer patients undergoing chemotherapy in the United States" 119 : 648-655, 2013

43 Kassubek R, "Identifying ischemic stroke associated with cancer : a multiple model derived from a case-control analysis" 264 : 781-791, 2017

44 이미지, "Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study" 대한뇌졸중학회 19 (19): 77-87, 2017

45 Park H, "Histological features of intracranial thrombi in stroke patients with cancer" 86 : 143-149, 2019

46 Simanek R, "High platelet count associated with venous thromboembolism in cancer patients : results from the Vienna Cancer and Thrombosis Study(CATS)" 8 : 114-120, 2010

47 Bang OY, "Evaluation of cryptogenic stroke with advanced diagnostic techniques" 45 : 1186-1194, 2014

48 Navi BB, "Enoxaparin vs aspirin in patients with cancer and ischemic stroke : the TEACH pilot randomized clinical trial" 75 : 379-381, 2018

49 Poppert H, "Embolic signals in unselected stroke patients : prevalence and diagnostic benefit" 37 : 2039-2043, 2006

50 Van Middelaar T, "Effect of antihypertensive medication on cerebral small vessel disease : a systematic review and metaanalysis" 49 : 1531-1533, 2018

51 Raskob GE, "Edoxaban for the treatment of cancer-associated venous thromboembolism" 378 : 615-624, 2018

52 Ornello R, "Distribution and temporal trends from 1993 to 2015of ischemic stroke subtypes : a systematic review and metaanalysis" 49 : 814-819, 2018

53 Vedovati MC, "Direct oral anticoagulants in patients with VTE and cancer : a systematic review and meta-analysis" 147 : 475-483, 2015

54 Merkler AE, "Diagnostic yield of echocardiography in cancer patients with ischemic stroke" 123 : 115-121, 2015

55 Nam KW, "Ddimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer" 24 : 205-211, 2017

56 Khorana AA, "Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis" 1 : 14-22, 2017

57 Jang H, "Comparison of enoxaparin and warfarin for secondary prevention of cancer-associated stroke" 2015 : 502089-, 2015

58 Seok JM, "Coagulopathy and embolic signal in cancer patients with ischemic stroke" 68 : 213-219, 2010

59 Kim SJ, "Clues to occult cancer in patients with ischemic stroke" 7 : e44959-, 2012

60 Seok JM, "Clinical presentation and ischemic zone on MRI in cancer patients with acute ischemic stroke" 68 : 368-376, 2012

61 Kim JM, "Clinical manifestation of cancer related stroke : retrospective casecontrol study" 111 : 295-301, 2013

62 Adams HP Jr, "Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment" 24 : 35-41, 1993

63 Bang OY, "Circulating DNAs, a marker of neutrophil extracellular traposis and cancer-related stroke: the OASIS-Cancer Study" 50 : 2944-2947, 2019

64 Yamamoto A, "Characteristics of intravascular large B-cell lymphoma on cerebral MR imaging" 33 : 292-296, 2012

65 Gon Y, "Characteristics of cryptogenic stroke in cancer patients" 3 : 280-287, 2016

66 Ito S, "Changes in serial D-dimer levels predict the prognoses of Trousseau’s syndrome patients" 9 : 528-, 2018

67 Graus F, "Cerebrovascular complications in patients with cancer" 64 : 16-35, 1985

68 Selvik HA, "Cancerassociated stroke : the Bergen NORSTROKE study" 5 : 107-113, 2015

69 Ay C, "Cancer-associated venous thromboembolism:burden, mechanisms, and management" 117 : 219-230, 2017

70 Grazioli S, "Cancer-associated ischemic stroke : a retrospective multicentre cohort study" 165 : 33-37, 2018

71 Bang OY, "Cancer cell-derived extracellular vesicles are associated with coagulopathy causing ischemic stroke via tissue factor-independent way : the OASIS-CANCER Study" 11 : e0159170-, 2016

72 Chung JW, "Association of cancer cell type and extracellular vesicles with coagulopathy in patients with lung cancer and stroke" 49 : 1282-1285, 2018

73 Navi BB, "Association between incident cancer and subsequent stroke" 77 : 291-300, 2015

74 Navi BB, "Arterial thromboembolic events preceding the diagnosis of cancer in older persons" 133 : 781-789, 2019

75 Kearon C, "Antithrombotic therapy for VTE disease : CHEST guideline and expert panel report" 149 : 315-352, 2016

76 Thompson CM, "Analysis of the autopsy records of 157 cases of carcinoma of the pancreas with particular reference to the incidence of thromboembolism" 223 : 469-478, 1952

77 Ay H, "An evidence-based causative classification system for acute ischemic stroke" 58 : 688-697, 2005

78 Uemura J, "Acute stroke patients have occult malignancy more often than expected" 64 : 140-144, 2010

79 Singhal AB, "Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis : a diffusion-weighted magnetic resonance imaging study" 33 : 1267-1273, 2002

80 Semenza GL, "A new weapon for attacking tumor blood vessels" 358 : 2066-2067, 2008

81 Pabinger I, "A clinical prediction model for cancer-associated venous thromboembolism : a development and validation study in two independent prospective cohorts" 5 : e289-e298, 2018